News
Alvotech (NASDAQ: ALVO, ALVO-SDB, the “Company”), a global biotech company specializing in the development and manufacture of ...
1d
TipRanks on MSNAlvo Minerals Launches $1.56 Million Entitlement OfferAn announcement from Alvo Minerals Limited ( ($AU:ALV) ) is now available. Alvo Minerals Limited has announced a pro-rata accelerated ...
US airlines are closely watching close-in booking trends, after demand softened in some passenger segments in 1Q2025. Copa ...
The average of price targets set by Wall Street analysts indicates a potential upside of 72.6% in Alvotech (ALVO). While the effectiveness of this highly sought-after metric is questionable, the ...
Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.
Dr. Reddy teams up with Alvotech to co-develop and commercialize a biosimilar of MRK's Keytruda, aiming to expand its biosimilars footprint.
Alvotech (ALVO) and Dr. Reddy’s Laboratories (RDY) have entered into a collaboration and license agreement to co-develop, ...
DELHI—International Airlines Group (IAG) CEO Luis Gallego has taken up his role as chair of the IATA board, while LATAM ...
A live video webcast of the presentation will be available to the general public and can be accessed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results